Literature DB >> 30223066

Regulation of sex hormone receptors in sexual dimorphism of human cancers.

Daoshan Zheng1, Cecilia Williams2, Jeremy A Vold3, Justin H Nguyen4, Denise M Harnois4, Sanjay P Bagaria4, Sarah A McLaughlin4, Zhaoyu Li5.   

Abstract

Gender differences in the incidences of cancers have been found in almost all human cancers. However, the mechanisms that underlie gender disparities in most human cancer types have been under-investigated. Here, we provide a comprehensive overview of potential mechanisms underlying sexual dimorphism of each cancer regarding sex hormone signaling. Fully addressing the mechanisms of sexual dimorphism in human cancers will greatly benefit current development of precision medicine. Our discussions of potential mechanisms underlying sexual dimorphism in each cancer will be instructive for future cancer research on gender disparities.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Androgen receptor; Cancer incidence; Estrogen receptor; Sex hormones; Sexual dimorphism

Mesh：

Substances：

Year:  2018        PMID： 30223066      PMCID： PMC6287770          DOI： 10.1016/j.canlet.2018.09.001

Source DB:  PubMed          Journal:  Cancer Lett        ISSN： 0304-3835            Impact factor:   8.679


  166 in total

1.  Androgens inhibit proliferation of human peripheral blood lymphocytes in vitro.

Authors:  D Lehmann; K Siebold; L R Emmons; H Müller
Journal:  Clin Immunol Immunopathol       Date:  1988-01

2.  Androgen receptor expression in human thyroid cancer tissues: a potential mechanism underlying the gender bias in the incidence of thyroid cancers.

Authors:  J A Stanley; M M Aruldhas; M Chandrasekaran; R Neelamohan; E Suthagar; K Annapoorna; S Sharmila; J Jayakumar; G Jayaraman; N Srinivasan; S K Banu
Journal:  J Steroid Biochem Mol Biol       Date:  2012-02-22       Impact factor: 4.292

3.  Estrogen receptor subtype expression and regulation is altered in papillary thyroid cancer after menopause.

Authors:  Gustavo A Rubio; Paola Catanuto; Marilyn K Glassberg; John I Lew; Sharon J Elliot
Journal:  Surgery       Date:  2017-11-08       Impact factor: 3.982

4.  A novel PALB2 truncating mutation in an Italian family with male breast cancer.

Authors:  Maria Teresa Vietri; Gemma Caliendo; Amelia Casamassimi; Michele Cioffi; Maria Laura De Paola; Claudio Napoli; Anna Maria Molinari
Journal:  Oncol Rep       Date:  2014-12-22       Impact factor: 3.906

5.  Lung cancer incidence in never smokers.

Authors:  Heather A Wakelee; Ellen T Chang; Scarlett L Gomez; Theresa H Keegan; Diane Feskanich; Christina A Clarke; Lars Holmberg; Lee C Yong; Laurence N Kolonel; Michael K Gould; Dee W West
Journal:  J Clin Oncol       Date:  2007-02-10       Impact factor: 44.544

6.  Growth of head and neck squamous cell carcinoma in nude mice: potentiation of laryngeal carcinoma by 17 beta-estradiol.

Authors:  K D Somers; M Koenig; G L Schechter
Journal:  J Natl Cancer Inst       Date:  1988-07-06       Impact factor: 13.506

7.  Chemoprevention of BBN-Induced Bladder Carcinogenesis by the Selective Estrogen Receptor Modulator Tamoxifen.

Authors:  Suraj Konnath George; Veronica Tovar-Sepulveda; Steven S Shen; Weiguo Jian; Yiqun Zhang; Susan G Hilsenbeck; Seth P Lerner; Carolyn L Smith
Journal:  Transl Oncol       Date:  2013-06-01       Impact factor: 4.243

8.  Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.

Authors:  Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray
Journal:  Int J Cancer       Date:  2014-10-09       Impact factor: 7.396

9.  Agonist activation of estrogen receptor beta (ERβ) sensitizes malignant pleural mesothelioma cells to cisplatin cytotoxicity.

Authors:  Giulia Pinton; Arcangela G Manente; Antonio Daga; Michele Cilli; Maurizio Rinaldi; Stefan Nilsson; Laura Moro
Journal:  Mol Cancer       Date:  2014-10-02       Impact factor: 27.401

10.  Insufficient antibody validation challenges oestrogen receptor beta research.

Authors:  Sandra Andersson; Mårten Sundberg; Nusa Pristovsek; Ahmed Ibrahim; Philip Jonsson; Borbala Katona; Carl-Magnus Clausson; Agata Zieba; Margareta Ramström; Ola Söderberg; Cecilia Williams; Anna Asplund
Journal:  Nat Commun       Date:  2017-06-15       Impact factor: 14.919
View more
  6 in total

Review 1.  Hormone-Dependent Tumors and Sexuality in the Neuro-Oncology of Women (N.O.W.): Women's Brain Tumors, Gaps in Sexuality Considerations, and a Need for Evidence-Based Guidelines.

Authors:  Na Tosha N Gatson; Maria L Boccia; Kerianne R Taylor; Jada K O Mack; Ekokobe Fonkem
Journal:  Curr Oncol Rep       Date:  2021-08-27       Impact factor: 5.075

2.  ERβ and Inflammation.

Authors:  Linnea Hases; Amena Archer; Cecilia Williams
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

Review 3.  X- and Y-Linked Chromatin-Modifying Genes as Regulators of Sex-Specific Cancer Incidence and Prognosis.

Authors:  Rossella Tricarico; Emmanuelle Nicolas; Michael J Hall; Erica A Golemis
Journal:  Clin Cancer Res       Date:  2020-07-30       Impact factor: 12.531

4.  A novel tumor suppressor ZBTB1 regulates tamoxifen resistance and aerobic glycolysis through suppressing HER2 expression in breast cancer.

Authors:  Panhong Zhang; Yutao Yang; Kai Qian; Lianlian Li; Cuiping Zhang; Xiaoyi Fu; Xiumei Zhang; Huan Chen; Qiongqing Liu; Shengnan Cao; Jiajun Cui
Journal:  J Biol Chem       Date:  2020-07-20       Impact factor: 5.157

Review 5.  Influence of Androgens on Immunity to Self and Foreign: Effects on Immunity and Cancer.

Authors:  Isabel Ben-Batalla; María Elena Vargas-Delgado; Gunhild von Amsberg; Melanie Janning; Sonja Loges
Journal:  Front Immunol       Date:  2020-07-02       Impact factor: 7.561

6.  Editorial: Role of Sex Steroids and Their Receptor in Cancers.

Authors:  Pia Giovannelli; Pandurangan Ramaraj; Cecilia Williams
Journal:  Front Endocrinol (Lausanne)       Date:  2022-04-06       Impact factor: 6.055
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.